Company Valuation: Kobayashi Pharmaceutical Co., Ltd.

Data adjusted to current consolidation scope
Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Market Cap 1 704,427 650,295 503,841 463,131 403,511 423,804 - -
Change - -7.68% -22.52% -8.08% -12.87% 5.03% - -
Enterprise Value (EV) 1 596,011 546,554 424,992 398,232 333,575 361,792 354,006 348,133
Change - -8.3% -22.24% -6.3% -16.24% 8.46% -2.15% -1.66%
P/E 35.8x 34.8x 25.3x 46x 110x 42x 31.3x 25.3x
PBR 3.59x 3.47x 2.47x 2.18x 1.92x 2.01x 1.96x 1.9x
PEG - 12.08x 7.7x -0.9x -1.7x 0x 0.9x 1.1x
Capitalization / Revenue 4.54x 3.91x 2.9x 2.8x 2.43x 2.46x 2.36x 2.27x
EV / Revenue 3.84x 3.29x 2.45x 2.4x 2.01x 2.1x 1.97x 1.87x
EV / EBITDA 19.3x 17.1x 13.3x 12.1x 14.1x 16.5x 13.1x 11.1x
EV / EBIT 22.9x 20.5x 16.5x 16x 22.4x 27.8x 20.3x 16.2x
EV / FCF 31.8x 31.1x -350x -29.2x 68.5x 24.9x 23.1x 20.2x
FCF Yield 3.15% 3.22% -0.29% -3.42% 1.46% 4.02% 4.32% 4.95%
Dividend per Share 2 83 90 101 102 104 106 109.5 114.3
Rate of return 0.92% 1% 1.49% 1.64% 1.92% 1.86% 1.92% 2%
EPS 2 252.4 259.6 268.2 135.4 49.19 135.8 182.4 225.4
Distribution rate 32.9% 34.7% 37.7% 75.3% 211% 78.1% 60% 50.7%
Net sales 1 155,252 166,258 173,455 165,600 165,742 172,322 179,620 186,639
EBITDA 1 30,900 32,027 31,837 32,800 23,600 21,965 26,990 31,262
EBIT 1 26,065 26,669 25,780 24,860 14,923 13,012 17,481 21,464
Net income 1 19,715 20,022 20,338 10,067 3,656 10,155 13,660 16,493
Net Debt 1 -108,416 -103,741 -78,849 -64,899 -69,936 -62,013 -69,799 -75,671
Reference price 2 9,040.00 9,030.00 6,790.00 6,230.00 5,428.00 5,701.00 5,701.00 5,701.00
Nbr of stocks (in thousands) 77,923 72,015 74,203 74,339 74,339 74,339 - -
Announcement Date 2/4/22 2/14/23 2/9/24 2/10/25 2/10/26 - - -
1JPY in Million2JPY
Estimates

P/E, Detailed evolution



P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
21.58x4.12x15.08x2.99% 341B
18.63x2.75x12.15x3.47% 138B
24.5x3.67x15.42x2.36% 71.82B
40.69x6.55x28.44x2.27% 48.77B
19.93x2.79x11.62x4.45% 36.4B
34.02x2.59x14.39x1.58% 36.49B
22.87x1.67x10.72x2.2% 20.65B
20.15x1.29x8.38x1.3% 19.37B
15.84x1.52x8.73x3.36% 19.38B
Average 24.25x 3.00x 13.88x 2.66% 81.34B
Weighted average by Cap. 22.97x 3.63x 14.77x 2.92%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA



Year-on-year evolution of the Yield

  1. Stock Market
  2. Stocks
  3. 4967 Stock
  4. KOY Stock
  5. Valuation Kobayashi Pharmaceutical Co., Ltd.